Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Is vitamin D level important in pregnant women with COVID-19?

Değirmenci et al., Journal of Controversies in Obstetrics & Gynecology and Pediatrics, doi:10.51271/JCOGP-0035
Jul 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
ICU admission 51% Improvement Relative Risk Severe CT finding 36% Moderate/severe CT finding 26% Hospitalization time 17% Vitamin D for COVID-19  Değirmenci et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Retrospective 125 patients in Turkey (March 2020 - January 2021) Lower ICU admission (p=0.27) and progression (p=0.53), not sig. c19early.org Değirmenci et al., J. Controversies in.., Jul 2024 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 112 treatments. c19early.org
Retrospective 125 pregnant women hospitalized with COVID-19 in Turkey, showing no significant differences with vitamin D deficiency.
This is the 203rd of 211 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 248,027,826 vigintillion).
Study covers HCQ and vitamin D.
risk of ICU admission, 50.6% lower, RR 0.49, p = 0.27, high D levels (≥20ng/ml) 3 of 36 (8.3%), low D levels (<20ng/ml) 15 of 89 (16.9%), NNT 12.
severe CT finding, 36.0% lower, RR 0.64, p = 0.53, high D levels (≥20ng/ml) 3 of 16 (18.8%), low D levels (<20ng/ml) 17 of 58 (29.3%), NNT 9.5.
moderate/severe CT finding, 25.6% lower, RR 0.74, p = 0.25, high D levels (≥20ng/ml) 8 of 16 (50.0%), low D levels (<20ng/ml) 39 of 58 (67.2%), NNT 5.8.
hospitalization time, 16.7% lower, relative time 0.83, p = 0.48, high D levels (≥20ng/ml) 36, low D levels (<20ng/ml) 89.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Değirmenci et al., 30 Jul 2024, retrospective, Turkey, peer-reviewed, mean age 29.3, 7 authors, study period March 2020 - January 2021. Contact: mulayimsizer@hotmail.com.
This PaperVitamin DAll
Is vitamin D level important in pregnant women with COVID-19?
Ahmet Değirmenci, Sertaç Ayçiçek, Fatih Mehmet Fındık, Mulaim Sizer, Azize Pervin Değirmenci, Pelin Değirmenci Ayçiçek, Çiğdem Mermutluoğlu
Journal of Controversies in Obstetrics & Gynecology and Pediatrics, doi:10.51271/jcogp-0035
Aim: The COVID-19 pandemic started in Wuhan City, Hubei Province, China in late December 2019. In our study, we aimed to evaluate the effectiveness of vitamin D levels on the clinic of the disease, laboratory findings, severity of the disease and, length of hospital stay by grouping pregnant patients with a diagnosis of COVID-19 according to their vitamin D levels. Methods: A total of 125 patients were included. According to the vitamin D levels of the patients at the time of hospitalization, two groups were determined as below and above 20ng/ml, which is the limit of vitamin D deficiency. The patients in these two groups were compared in terms of demographic features, clinical findings, laboratory findings, imaging findings, hospitalization times and need for intensive care. Results: When evaluated according to serum 25 hydroxyvitamin D level, patients' fever, pulse, oxygen saturation, the severity of lung involvement in computed tomography, hospitalization there was no statistically significant difference between the groups in terms of duration and need for intensive care. When the laboratory parameters of the patients at hospitalization were compared according to serum 25 hydroxyvitamin D levels, there was no statistically significant difference between the two groups in terms of any laboratory parameter. As a result of the analysis, only lymphocyte count was determined as the independent variable affecting the severity of lung involvement in thorax CT (Computed tomography). As the lymphocyte count decreased, the severity of involvement in thorax CT increased. Conclusion: Our study showed that vitamin D level did not have a significant relationship with any of the parameters related to COVID-19 such as clinical and laboratory findings, severity of the disease and duration of hospitalisation. It is also supported by our study that the decrease in lymphocyte counts is associated with severe COVID-19 disease.
ETHICAL DECLARATIONS Ethics Committee Approval The study was carried out with the permission of the Informed Consent All patients signed and free and informed consent form. Referee Evaluation Process Externally peer-reviewed. Conflict of Interest Statement The authors have no conflicts of interest to declare. Financial Disclosure The authors declared that this study has received no financial support. Author Contributions All of the authors declare that they have all participated in the design, execution, and analysis of the paper, and that they have approved the final version.
References
Bouillon, Carmeliet, Verlinden, Vitamin D and human health: lessons from vitamin D receptor null mice, Endocr Rev
Chen, Mei, Xie, Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a metaanalysis and GRADE assessment of cohort studies and RCTs, Nutr J
Chen, Zhou, Dong, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet
Ejaz, Alsrhani, Zafar, COVID-19 and comorbidities: Deleterious impact on infected patients, J Infect Public Health
Fang, Li, Yu, Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and metaanalysis, Aging
Hastie, Pell, Sattar, Vitamin D and COVID-19 infection and mortality in UK Biobank, Eur J Nutr
Jakovac, COVID-19 and vitamin D-Is there a link and an opportunity for intervention?, Am J Physiol Endocrinol Metab
Kazemi, Mohammadi, Aghababaee, Golzarand, Clark et al., Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis, Adv Nutr
Liu, Stenger, Li, Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response, Science
Meng, Wang, Wen, Clinical features and laboratory examination to identify severe patients with COVID-19: a systematic review and meta-analysis, Biomed Res Int
Muralidar, Ambi, Sekaran, Krishnan, The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2, Biochimie
Müller, Diamant, Bendtzen, Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3, Immunol Lett
Oscanoa, Amado, Vidal, Laird, Ghashut et al., The relationship between the severity and mortality of SARS-CoV-2 infection and 25-hydroxyvitamin D concentration -a metaanalysis, Adv Respir Med
Pereira, Damascena, Azevedo, Oliveira, Santana, Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis, Crit Rev Food Sci Nutr
Rasmussen, Jamieson, COVID-19 and Pregnancy, Infect Dis Clin North Am
Sinaci, Öcal, Yetiskin, Impact of vitamin D on the course of COVID-19 during pregnancy: a case control study, J Steroid Biochem Mol Biol
Tripathi, Tecle, Verma, The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins, J Gen Virol
Wang, Zhao, Yang, Hu, Yao, Value of the neutrophillymphocyte ratio in predicting COVID-19 severity: a metaanalysis, Dis Markers
Wu, Mcgoogan, Characteristics of and important lessons from the Coronavirus disease (COVID-19) outbreak in China: summary of a report of 72 314 cases from the chinese center for disease control and prevention, JAMA
Zambrano, Ellington, Strid, Update: characteristics of symptomatic women of reproductive age with laboratoryconfirmed sars-cov-2 infection by pregnancy status -united states, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm6944e3
Zhou, Yu, Du, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [published correction appears in, Lancet
{ 'indexed': {'date-parts': [[2024, 8, 9]], 'date-time': '2024-08-09T00:10:17Z', 'timestamp': 1723162217242}, 'reference-count': 0, 'publisher': 'MediHealth Academy', 'issue': '3', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'abstract': '<jats:p>Aims: The Covid-19 pandemic started in Wuhan City, Hubei Province, China in late ' 'December 2019. In our study, we aimed to evaluate the effectiveness of vitamin D levels on ' 'the clinic of the disease, laboratory findings, severity of the disease and, length of ' 'hospital stay by grouping pregnant patients with a diagnosis of Covid-19 according to their ' 'vitamin D levels.\n' 'Methods: A total of 125 patients were included. According to the vitamin D levels of the ' 'patients at the time of hospitalization, two groups were determined as below and above ' '20ng/ml, which is the limit of vitamin D deficiency. The patients in these two groups were ' 'compared in terms of demographic features, clinical findings, laboratory findings, imaging ' 'findings, hospitalization times and need for intensive care.\n' 'Results: When evaluated according to serum 25 hydroxyvitamin D level, patients’ fever, pulse, ' 'oxygen saturation, the severity of lung involvement in computed tomography, hospitalization ' 'there was no statistically significant difference between the groups in terms of duration and ' 'need for intensive care. When the laboratory parameters of the patients at hospitalization ' 'were compared according to serum 25 hydroxyvitamin D levels, there was no statistically ' 'significant difference between the two groups in terms of any laboratory parameter. As a ' 'result of the analysis, only lymphocyte count was determined as the independent variable ' 'affecting the severity of lung involvement in thorax CT (Computed tomography). As the ' 'lymphocyte count decreased, the severity of involvement in thorax CT increased.\n' 'Conclusion: Our study showed that vitamin D level did not have a significant relationship ' 'with any of the parameters related to Covid-19 such as clinical and laboratory findings, ' 'severity of the disease and duration of hospitalisation. It is also supported by our study ' 'that the decrease in lymphocyte counts is associated with severe Covid-19 disease.</jats:p>', 'DOI': '10.51271/jcogp-0035', 'type': 'journal-article', 'created': {'date-parts': [[2024, 8, 8]], 'date-time': '2024-08-08T06:06:54Z', 'timestamp': 1723097214000}, 'page': '51-57', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Is vitamin D level important in pregnant women with COVID-19?', 'prefix': '10.51271', 'volume': '2', 'author': [ { 'ORCID': 'http://orcid.org/0000-0003-4685-3335', 'authenticated-orcid': False, 'given': 'Ahmet', 'family': 'Değirmenci', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-9306-6281', 'authenticated-orcid': False, 'given': 'Sertaç', 'family': 'Ayçiçek', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-9142-6127', 'authenticated-orcid': False, 'given': 'Fatih Mehmet', 'family': 'Fındık', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4864-7287', 'authenticated-orcid': False, 'given': 'Mulaim', 'family': 'Sizer', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0009-0006-1602-4009', 'authenticated-orcid': False, 'given': 'Azize Pervin', 'family': 'Değirmenci', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-0108-2856', 'authenticated-orcid': False, 'given': 'Pelin', 'family': 'Değirmenci Ayçiçek', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-1836-6281', 'authenticated-orcid': False, 'given': 'Çiğdem', 'family': 'Mermutluoğlu', 'sequence': 'additional', 'affiliation': []}], 'member': '28304', 'published-online': {'date-parts': [[2024, 7, 30]]}, 'container-title': 'Journal of Controversies in Obstetrics &amp; Gynecology and Pediatrics', 'original-title': [], 'deposited': { 'date-parts': [[2024, 8, 8]], 'date-time': '2024-08-08T06:06:57Z', 'timestamp': 1723097217000}, 'score': 1, 'resource': {'primary': {'URL': 'http://journal-jcogp.com/Publication/DisplayArticle/27358'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 7, 30]]}, 'references-count': 0, 'journal-issue': {'issue': '3', 'published-online': {'date-parts': [[2024, 7, 30]]}}, 'URL': 'http://dx.doi.org/10.51271/JCOGP-0035', 'relation': {}, 'ISSN': ['2980-0579'], 'subject': [], 'container-title-short': 'JCOGP', 'published': {'date-parts': [[2024, 7, 30]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit